selected publications
-
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.
Journal of clinical medicine.
2020
Academic Article
GET IT
Times cited: 23 -
Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
Leukemia research.
2020
Academic Article
GET IT
Times cited: 2 -
Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
PloS one.
2020
Academic Article
GET IT
Times cited: 24